Disclosures for "Greater Durations at High Mean Arterial Pressure Predicts Better Neurologic Outcomes in Post Arrest Patients"
-
Mr. Bao has nothing to disclose.
-
Mr. Houston has nothing to disclose.
-
Mr. Basu has nothing to disclose.
-
Mr. Velasquez has nothing to disclose.
-
Ms. Bains has nothing to disclose.
-
Ms. Peterson has nothing to disclose.
-
Dr. Lieberman has received research support from UCSF.
-
Miss Marques has nothing to disclose.
-
Dr. Singhal has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. The institution of Dr. Singhal has received research support from VA Office of Sponsored Research. The institution of Dr. Singhal has received research support from Bayer.
-
Dr. Hemphill has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zoll. Dr. Hemphill has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for various legal firms. The institution of Dr. Hemphill has received research support from NIH/NINDS.
-
The institution of Dr. Amorim has received research support from American Heart Association. The institution of Dr. Amorim has received research support from Society of Critical Care Medicine. The institution of Dr. Amorim has received research support from Zoll Foundation. The institution of Dr. Amorim has received research support from Hellman Foundation. The institution of Dr. Amorim has received research support from Regents of the University of California. The institution of Dr. Amorim has received research support from Citizens United Against Epilepsy. The institution of Dr. Amorim has received research support from Regents of the University of California. The institution of Dr. Amorim has received research support from American Heart Association. The institution of Dr. Amorim has received research support from NIH. The institution of Dr. Amorim has received research support from Department of Defense.